New research: Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity: Bone metastasis is the leading cause of prostate cancer (PCa) mortality, frequently marking the progression to… https://t.
6,531 followers
906 followers
New article: Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity. https://t.co/Cm5qQqpQ7H #prostatecancer #oncology https://t.co/fVqRZrW6JJ
2,610 followers
RT @MariannKrutihof: Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity…
69 followers
RT @MariannKrutihof: Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity…